U.S. Markets open in 1 hr 11 mins

Getting technical: Buyers in control of Crispr Therapeutics (CRSP)

Joining Yahoo Finance's Jen Rogers and Myles Udland is Brian Shannon, CMT and founder of www.alphatrends.net, who breaks down the bullish action in Crispr.